BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SFARI - ECPv6.6.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.sfari.org
X-WR-CALDESC:Events for SFARI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20170125T170000
DTEND;TZID=UTC:20170125T181500
DTSTAMP:20260513T152902
CREATED:20170125T100000Z
LAST-MODIFIED:20180216T201620Z
UID:1994-1485363600-1485368100@www.sfari.org
SUMMARY:Potholes and progress on the road to translational treatments in autism spectrum disorder
DESCRIPTION:  \n\nOn 25 January 2017\, Jeremy Veenstra-VanderWeele outlined critical challenges to translating genomic\, cellular\, and animal model research into new treatments for autism spectrum disorder. \nHis talk was part of the Simons Foundation Autism Research lecture series. \nAbout the Lecture\nEmerging genomic and neuroscience findings have delivered hypotheses that are now being tested in autism spectrum disorder (ASD) and related genetic syndromes. Unfortunately\, these clinical trials have not yet yielded positive results\, suggesting a need to step back and evaluate the science of testing new treatments for neurodevelopmental disorders. \nIn this lecture\, Jeremy Veenstra-VanderWeele outlined critical challenges\, both conceptual and practical\, to translating genomic\, cellular\, and animal model research into new treatments for ASD. He discussed the limitations to conclusions drawn from work in the laboratory as they are extrapolated to the clinic. He also described common pitfalls in clinical trials\, including mismatches between hypotheses and study populations\, substantial “placebo” effects\, and subjective outcome measures. Framing these challenges in the context of past successes in ASD treatment research\, he suggested guideposts as we work toward neurobiologically based treatments for ASD. \nAbout the speaker:\nJeremy Veenstra-VanderWeele is the Mortimer D. Sackler\, M.D.\, Associate Professor in Psychiatry at Columbia University Medical Center and the New York State Psychiatric Institute. He completed his M.D. and residency training at the University of Chicago\, postdoctoral training in neuroscience at Vanderbilt University\, and moved to Columbia in 2014. As a child psychiatrist and developmental neuroscientist\, his primary motivation is to deliver new treatments to children with autism spectrum disorder and related neurodevelopmental disorders. \n 
URL:https://www.sfari.org/event/potholes-and-progress-on-the-road-to-translational-treatments-in-autism-spectrum-disorder/
LOCATION:Gerald D. Fischbach Auditorium\, 160 5th Avenue\, New York\, NY\, 10010\, United States
ATTACH;FMTTYPE=image/jpeg:https://sf-web-assets-prod.s3.amazonaws.com/wp-content/uploads/sites/2/2017/07/04165902/JeremyVeenstra250.jpg
END:VEVENT
END:VCALENDAR